Related Experiment Video
Updated: Dec 2, 2025
09:43
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
3.3K
Update on Lupus Nephritis: Looking for a New Vision
Enrique Morales1,2, Maria Galindo3,4, Hernando Trujillo5,3
1Department of Nephrology, University Hospital "12 de Octubre", Madrid, Spain, emoralesr@senefro.org.
Nephron
|November 4, 2020
Summary
Lupus nephritis (LN) significantly impacts patients with systemic lupus erythematosus (SLE), necessitating improved biomarkers and personalized treatments. Current therapies offer limited remission rates, highlighting the urgent need for optimized strategies and novel agents to enhance patient outcomes.
Area of Science:
- Nephrology
- Rheumatology
- Immunology
Background:
- Lupus nephritis (LN) affects 40% of systemic lupus erythematosus (SLE) patients, leading to end-stage kidney disease (ESKD) in 10%.
- Current LN therapies achieve remission in only 60-70% of patients, indicating a need for better treatment strategies.
- Significant gaps exist in understanding optimal immunosuppressive treatment, steroid withdrawal timing, and managing pregnancy and transplantation in LN patients.
Purpose of the Study:
- To highlight the critical need for improved clinical biomarkers and histological classifications for personalized lupus nephritis treatment.
- To emphasize the necessity of optimizing existing therapies and developing novel agents for lupus nephritis.
- To identify key areas for future research, including treatment duration, steroid withdrawal, drug toxicity, pregnancy, and kidney transplantation in LN.
Main Methods:
- Review of recent publications and clinical trial data concerning lupus nephritis management.
- Analysis of therapeutic outcomes and identification of unmet needs in LN treatment.
- Exploration of the role of repeat kidney biopsies in guiding precision medicine approaches.
Main Results:
- Existing lupus nephritis therapies have suboptimal remission rates, underscoring the need for advancement.
- Repeat kidney biopsies show potential utility in tailoring treatment decisions for precision medicine.
- Critical knowledge gaps persist regarding optimal immunosuppressive regimens, steroid use, and specific patient populations (pregnancy, transplantation).
Conclusions:
- Significant improvements are required in lupus nephritis management, including biomarker discovery and refined histological classification.
- Optimizing current treatments and developing new therapeutic agents are crucial for improving patient survival and reducing ESKD rates.
- Future clinical trials must address specific unanswered questions to enhance long-term outcomes for lupus nephritis patients.
Related Concept Videos
01:26Nephrotic Syndrome II : Assessment and Medical Management
101
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
101
01:24Nephrotic Syndrome I : Introduction
298
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
298
01:29Acute Kidney Injury II: Pathophysiology
603
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
603
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
167
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
167
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
170
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
170
01:24Nephrotic Syndrome III : Nursing Management
167
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
167